Literature DB >> 1474772

Clinical and pathologic features of fibrillary glomerulonephritis.

S S Iskandar1, R J Falk, J C Jennette.   

Abstract

A diagnosis of fibrillary glomerulonephritis was made in 31 renal biopsies from 28 patients on the basis of the electron microscopic identification of glomerular deposits of randomly arranged fibrils that resembled amyloidosis but were larger. This accounted for approximately 1% of all nontransplant renal biopsy diagnoses. Renal biopsy specimens with parallel arrays of 30 nm to 50 nm microtubules (that is, immunotactoid glomerulopathy) were not included in the study. The patients had a mean age of 49 years with a range of 21 to 75. The male to female ratio was 1:1.8 and the ratio of Whites to Blacks was 8.3:1, which differs from the 3:1 ratio in our overall biopsy population. All patients had proteinuria (mean 6.0 g/day), and most had hematuria and renal insufficiency. After a mean follow-up of 24 months, there was 48% renal survival. The light microscopic appearance of the fibrillary glomerulonephritis was quite varied. Capillary wall thickening and matrix expansion were the most frequent alterations. Nineteen percent of specimens had crescents. Morphometric ultrastructural analysis demonstrated a mean fibril diameter of 22.4 +/- 7.4 nm. Immunofluorescence microscopy revealed that IgG was the dominant and often the only immunoglobulin class in immune deposits, and subclass analysis revealed that IgG4 was the dominant or exclusive subclass in all specimens tested. We hypothesize that the relatively homogeneous nature of the immunoglobulin in the immune deposits is the basis for the fibril formation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1474772     DOI: 10.1038/ki.1992.433

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  41 in total

1.  Fibrillary glomerulonephritis.

Authors:  Wako Yumura
Journal:  Clin Exp Nephrol       Date:  2005-09       Impact factor: 2.801

2.  Glomerular mesangial fibrillary deposits in a patient with diabetes mellitus.

Authors:  Ipek Isik Gonul; James Gough; Kim Jim; Hallgrimur Benediktsson
Journal:  Int Urol Nephrol       Date:  2007-01-09       Impact factor: 2.370

3.  Fibrillary glomerulonephritis associated with monoclonal gammopathy of undetermined significance showing lambda-type Bence Jones protein.

Authors:  Tomoaki Nagao; Takafumi Okura; Ken-Ichi Miyoshi; Sanae Watanabe; Seiko Manabe; Mie Kurata; Jun Irita; Tomikazu Fukuoka; Jitsuo Higaki
Journal:  Clin Exp Nephrol       Date:  2005-09       Impact factor: 2.801

4.  Treatment of fibrillary glomerulonephritis by corticosteroids and tripterygium glycoside tablets: A case report.

Authors:  Zhao-Yu Lu; Hai-Feng Yang; Yu Peng; Yin Li; Zi-Chang Yin; Fu-Hua Lu; Xu-Sheng Liu
Journal:  Chin J Integr Med       Date:  2016-03-29       Impact factor: 1.978

5.  Fibrillary glomerulonephritis: a report of 66 cases from a single institution.

Authors:  Samih H Nasr; Anthony M Valeri; Lynn D Cornell; Mary E Fidler; Sanjeev Sethi; Nelson Leung; Fernando C Fervenza
Journal:  Clin J Am Soc Nephrol       Date:  2011-03-24       Impact factor: 8.237

6.  Fibrillary glomerulonephritis in a patient with systemic lupus erythematosus: a rare association.

Authors:  Zeenat Y Bhat; Xu Zeng; Jaideep Hingorani; Salman Khan; Madhumita Jena Mohanty
Journal:  Int Urol Nephrol       Date:  2011-11-19       Impact factor: 2.370

Review 7.  Paraprotein-Related Kidney Disease: Glomerular Diseases Associated with Paraproteinemias.

Authors:  Shveta S Motwani; Leal Herlitz; Divya Monga; Kenar D Jhaveri; Albert Q Lam
Journal:  Clin J Am Soc Nephrol       Date:  2016-08-15       Impact factor: 8.237

8.  A case of fibrillary glomerulonephritis with unusual IgM deposits and hypocomplementemia.

Authors:  Yoon Hee Shim; Seung Joo Lee; Sun Hee Sung
Journal:  Pediatr Nephrol       Date:  2008-02-21       Impact factor: 3.714

9.  Immunotactoid glomerulonephritis in a child with HIV infection: a case report.

Authors:  Gertruida van Biljon; Melanie Louw; Leonora Dreyer
Journal:  Pediatr Nephrol       Date:  2007-04-25       Impact factor: 3.714

Review 10.  Renal replacement therapy in multiple myeloma and systemic amyloidosis.

Authors:  J H Brown; C C Doherty
Journal:  Postgrad Med J       Date:  1993-09       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.